There is currently a study being conducted in Europe to test a new method of administration of AI's. Women who have already had 5 years of tx are being tested on a 3 month on, 3 month off dosing schedule vs. I believe continuous dosing.
IMO, these studies show that we can do a better job with the exisiting drugs on the market if we work at determining the optimum way to use them. Too little work is done with dosing schedules and amounts once they hit the market.
Hopeful
|